{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:48:59Z","timestamp":1778888939343,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hfc.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:29:40Z","timestamp":1735561780000},"page":"e11-e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S","title":["PET and Cardiac Amyloidosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Alberto","family":"Aimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Fu","family":"Ferrari Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Valleggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assuero","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Vergaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2024.09.006_bib1","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/2047487319877708","article-title":"Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings","volume":"27","author":"Vergaro","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/jama.1968.03140200068026","article-title":"Amyloidosis of the heart. Possible pitfall in the diagnosis of pericardial effusion by scintillation scanning","volume":"204","author":"Hauser","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2024.09.006_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0002-8703(89)90080-X","article-title":"Fowler NO. Differentiation of constrictive percarditis and restrictive cardiomyopathy by radionuclide ventriculography","volume":"118","author":"Gerson","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2024.09.006_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1006210913708","article-title":"Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis","volume":"15","author":"Kodama","year":"1999","journal-title":"Int J Card Imag"},{"key":"10.1016\/j.hfc.2024.09.006_bib5","first-page":"2049","article-title":"Technetium-99m (V) DMSA uptake in amyloidosis","volume":"30","author":"Ohta","year":"1989","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","article-title":"Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy","volume":"6","author":"Coutinho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/13506129.2020.1769059","article-title":"Cardiac sympathetic denervation in wild-type transthyretin amyloidosis","volume":"27","author":"Gimelli","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.09.006_bib8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2020.1744553","article-title":"The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease","volume":"27","author":"Azevedo Coutinho","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.09.006_bib10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib11","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.09.006_bib12","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.09.006_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-020-01284-3","article-title":"Advances in PET-based cardiac amyloid radiotracers","volume":"22","author":"Gallegos","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2024.09.006_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s12350-021-02524-x","article-title":"Positron emission tomography for cardiac amyloidosis: timing matters","volume":"29","author":"Singh","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In\u00a0vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2019.11.037","article-title":"Pittsburgh B compound positron emission tomography in patients with AL cardiac amyloidosis","volume":"75","author":"Lee","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [11C]PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/13506129.2020.1798223","article-title":"Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging","volume":"27","author":"Takasone","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.09.006_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/RLU.0000000000003665","article-title":"Noninvasive detection of cardiac amyloid with 11C-Pittsburgh compound B PET\/CT and 99mTc-PYP scintigraphy","volume":"46","author":"Wang","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2967\/jnumed.121.263033","article-title":"Independent prognostic utility of 11C-Pittsburgh compound B PET in patients with light-chain cardiac amyloidosis","volume":"63","author":"Choi","year":"2022","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12350-018-1260-5","article-title":"Significance of 11C-PIB PET\/CT in cardiac amyloidosis compared with 99mTc-aprotinin scintigraphy: a pilot study","volume":"27","author":"Minamimoto","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hfc.2024.09.006_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-015-3208-1","article-title":"Imaging \u03b2-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis","volume":"43","author":"Heurling","year":"2016","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.hfc.2024.09.006_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/RLU.0000000000000492","article-title":"Is 18F-flutemetamol PET\/CT able to reveal cardiac amyloidosis?","volume":"39","author":"Lhommel","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13506129.2020.1760237","article-title":"Quantification of cardiac amyloid with [18F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis","volume":"27","author":"M\u00f6ckelind","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.09.006_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12350-020-02363-2","article-title":"18F-flutemetamol positron emission tomography in cardiac amyloidosis","volume":"29","author":"Papathanasiou","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13506129.2022.2141623","article-title":"The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis","volume":"30","author":"Abrahamson","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.09.006_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMp1208061","article-title":"Brain amyloid imaging--FDA approval of florbetapir F18 injection","volume":"367","author":"Yang","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2024.09.006_bib31","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 1\u2078F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.hfc.2024.09.006_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A\u00a0routine PET\/CT protocol with Streamlined calculations for assessing cardiac amyloidosis using (18)F-florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.hfc.2024.09.006_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ehjci\/jead350","article-title":"Quantification of right ventricular amyloid burden with 18f-florbetapir PET\/CT and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis","volume":"25","author":"Datar","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib35","doi-asserted-by":"crossref","first-page":"693194","DOI":"10.3389\/fcvm.2021.693194","article-title":"Pilot study of F18-florbetapir in the early evaluation of cardiac amyloidosis","volume":"8","author":"Sperry","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13506129.2018.1552852","article-title":"A\u00a0pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement","volume":"25","author":"Manwani","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.09.006_bib37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-018-0425-1","article-title":"18F-florbetaben whole-body PET\/MRI for evaluation of systemic amyloid deposition","volume":"8","author":"Baratto","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.hfc.2024.09.006_bib39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.hfc.2024.09.006_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib41","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s12350-021-02608-8","article-title":"Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images","volume":"29","author":"Santarelli","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib42","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s10554-021-02190-7","article-title":"Deep-learning-based cardiac amyloidosis classification from early acquired pet images","volume":"37","author":"Santarelli","year":"2021","journal-title":"Int J Cardiovasc Imag"},{"key":"10.1016\/j.hfc.2024.09.006_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s12350-015-0287-0","article-title":"[18F]-NaF PET\/CT imaging in cardiac amyloidosis","volume":"23","author":"Van Der Gucht","year":"2016","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib44","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s12350-017-0799-x","article-title":"18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis","volume":"25","author":"Morgenstern","year":"2018","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12350-019-01675-2","article-title":"Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis","volume":"28","author":"Martineau","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12350-020-02356-1","article-title":"18F-fluoride PET\/MR in cardiac amyloid: a comparison study with aortic stenosis and age- and sex-matched controls","volume":"29","author":"Andrews","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib47","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s12350-020-02425-5","article-title":"Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis","volume":"29","author":"Zhang","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/ph16040629","article-title":"Clinical confirmation of pan-amyloid reactivity of radioiodinated peptide 124I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET\/CT imaging","volume":"16","author":"Martin","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.hfc.2024.09.006_bib49","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine (124I) evuzamitide (124I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib50","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","article-title":"18F-Sodium fluoride PET\/MR for the assessment of cardiac amyloidosis","volume":"68","author":"Trivieri","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib51","doi-asserted-by":"crossref","first-page":"830572","DOI":"10.3389\/fcvm.2022.830572","article-title":"Diagnostic value of 11C-PIB PET\/MR in cardiac amyloidosis","volume":"9","author":"Bi","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hfc.2024.09.006_bib52","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s12350-019-01885-8","article-title":"18F-sodium fluoride PET\/MRI myocardial imaging in patients with suspected cardiac amyloidosis","volume":"28","author":"Abulizi","year":"2021","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib54","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: a practical approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","article-title":"Cardiac amyloidosis imaging with amyloid positron emission tomography: a systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hfc.2024.09.006_bib56","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.09.006_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00259-023-06381-3","article-title":"Positron emission tomography in the diagnosis and follow-up of transthyretin amyloid cardiomyopathy patients: a systematic review","volume":"51","author":"Tingen","year":"2023","journal-title":"Eur J Nucl Med Mol Imag"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:54:48Z","timestamp":1750852488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1551713624000837"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.09.006","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET and Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}